{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:27:19Z","timestamp":1792801639371,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Research and Development Plan of Jining","award":["2023YXNS012"],"award-info":[{"award-number":["2023YXNS012"]}]},{"name":"Post-doctoral Program of Affiliated Hospital of Jining Medical University","award":["JYFY401713"],"award-info":[{"award-number":["JYFY401713"]}],"id":[{"id":"https:\/\/ror.org\/05e8kbn88","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Cultivation Plan of High-level Scientific Research Projects of Jining Medical University","award":["JYGC2023FKJ001"],"award-info":[{"award-number":["JYGC2023FKJ001"]}],"id":[{"id":"https:\/\/ror.org\/03zn9gq54","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-025-00816-8","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T07:53:09Z","timestamp":1756626789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel splice-altering frameshift variant in the COL1A1 gene underlies osteogenesis imperfecta type I: molecular characterization of a four-generation Chinese pedigree and literature review"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6704-7354","authenticated-orcid":false,"given":"Dongye","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuoshuo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,31]]},"reference":[{"issue":"8","key":"816_CR1","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.eprac.2022.05.003","volume":"28","author":"SS Wei","year":"2022","unstructured":"Wei SS, Yao YY, Shu M, Gao L, Zhao JJ, Li TY, et al. Genotype-phenotype relationship and follow-up analysis of a Chinese cohort with osteogenesis imperfecta. Endocr Pract. 2022;28(8):760\u20136.","journal-title":"Endocr Pract"},{"issue":"1","key":"816_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1210\/endrev\/bnab017","volume":"43","author":"M Jovanovic","year":"2022","unstructured":"Jovanovic M, Guterman-Ram G, Marini JC. Osteogenesis imperfecta: mechanisms and signaling pathways connecting classical and rare OI types. Endocr Rev. 2022;43(1):61\u201390.","journal-title":"Endocr Rev"},{"issue":"1","key":"816_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1021\/acsptsci.3c00324","volume":"7","author":"Y Sun","year":"2024","unstructured":"Sun Y, Li L, Wang J, Liu H, Wang H. Emerging landscape of osteogenesis imperfecta pathogenesis and therapeutic approaches. ACS Pharmacol Transl Sci. 2024;7(1):72\u201396.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"816_CR4","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","volume":"3","author":"JC Marini","year":"2017","unstructured":"Marini JC, Forlino A, B\u00e4chinger HP, Bishop NJ, Byers PH, De Paepe A, et al. Osteogenesis imperfecta. Nat Rev Dis Primers. 2017;3:17052.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"816_CR5","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1210\/jc.2013-1505","volume":"98","author":"JC Marini","year":"2013","unstructured":"Marini JC, Blissett AR. New genes in bone development: what\u2019s new in osteogenesis imperfecta. J Clin Endocrinol Metab. 2013;98(8):3095\u2013103.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"816_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000494491","volume":"84","author":"A Alhousseini","year":"2019","unstructured":"Alhousseini A, Mahaseth M, Zeineddine S, Jaiman S, Berman S, Bryant D, et al. A non-lethal osteogenesis imperfecta type II mutation. Gynecol Obstet Invest. 2019;84(2):204\u20138.","journal-title":"Gynecol Obstet Invest"},{"issue":"6","key":"816_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/MOP.0000000000000813","volume":"31","author":"V Rossi","year":"2019","unstructured":"Rossi V, Lee B, Marom R. Osteogenesis imperfecta: advancements in genetics and treatment. Curr Opin Pediatr. 2019;31(6):708\u201315.","journal-title":"Curr Opin Pediatr"},{"key":"816_CR8","doi-asserted-by":"publisher","first-page":"e5464","DOI":"10.7717\/peerj.5464","volume":"6","author":"M Rousseau","year":"2018","unstructured":"Rousseau M, Retrouvey JM. Members of the brittle bone disease C. Osteogenesis imperfecta: potential therapeutic approaches. Peer J. 2018;6:e5464.","journal-title":"Peer J"},{"issue":"1","key":"816_CR9","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.1038\/s41467-021-27563-3","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen Y, Yang SJ, Lovisa S, Ambrose CG, McAndrews KM, Sugimoto H, et al. Type-I collagen produced by distinct fibroblast lineages reveals specific function during embryogenesis and osteogenesis imperfecta. Nat Commun. 2021;12(1):7199.","journal-title":"Nat Commun"},{"key":"816_CR10","doi-asserted-by":"publisher","first-page":"100757","DOI":"10.1016\/j.diff.2024.100757","volume":"136","author":"V Selvaraj","year":"2024","unstructured":"Selvaraj V, Sekaran S, Dhanasekaran A, Warrier S. Type 1 collagen: synthesis, structure and key functions in bone mineralization. Differentiation. 2024;136:100757.","journal-title":"Differentiation"},{"issue":"4","key":"816_CR11","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1530\/EJE-20-0299","volume":"183","author":"R Marom","year":"2020","unstructured":"Marom R, Rabenhorst BM, Morello R. Osteogenesis imperfecta: an update on clinical features and therapies. Eur J Endocrinol. 2020;183(4):R95\u2013106.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"816_CR12","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00198-021-06263-0","volume":"33","author":"L Yang","year":"2022","unstructured":"Yang L, Liu B, Dong XR, Wu J, Sun CJ, Xi L, et al. Clinical severity prediction in children with osteogenesis imperfecta caused by defects. Osteoporos Int. 2022;33(6):1373\u201384.","journal-title":"Osteoporos Int"},{"issue":"8","key":"816_CR13","doi-asserted-by":"publisher","first-page":"e1996","DOI":"10.1002\/mgg3.1996","volume":"10","author":"K Salacinska","year":"2022","unstructured":"Salacinska K, Michalus I, Pinkier I, Rutkowska L, Chlebna-Sok\u00f3l D, Jakubowska-Pietkiewicz E, et al. The first glycine-to-tryptophan substitution in the gene identified in a patient with progressively-deforming osteogenesis imperfecta. Mol Genet Genom Med. 2022;10(8):e1996.","journal-title":"Mol Genet Genom Med"},{"issue":"11","key":"816_CR14","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1007\/s00198-016-3653-0","volume":"27","author":"JD Hald","year":"2016","unstructured":"Hald JD, Folkestad L, Harslof T, Lund AM, Duno M, Jensen JB, et al. Skeletal phenotypes in adult patients with osteogenesis imperfecta-correlations with\/genotype and collagen structure. Osteoporos Int. 2016;27(11):3331\u201341.","journal-title":"Osteoporos Int"},{"issue":"9","key":"816_CR15","doi-asserted-by":"publisher","first-page":"e1366","DOI":"10.1002\/mgg3.1366","volume":"8","author":"YX Han","year":"2020","unstructured":"Han YX, Wang DM, Guo JL, Xiong QH, Li P, Zhou YA, et al. A novel splicing pathogenic variant in causing osteogenesis imperfecta (OI) type I in a Chinese family. Mol Genet Genom Med. 2020;8(9):e1366.","journal-title":"Mol Genet Genom Med"},{"issue":"3","key":"816_CR16","doi-asserted-by":"publisher","first-page":"e63935","DOI":"10.1002\/ajmg.a.63935","volume":"197","author":"D Batkovskyte","year":"2025","unstructured":"Batkovskyte D, Swolin-Eide D, Hammarsjo A, Saether KB, Thunstrom S, Lundin J, et al. Structural variants in COL1A1 and COL1A2 in osteogenesis imperfecta. Am J Med Genet A. 2025;197(3):e63935.","journal-title":"Am J Med Genet A"},{"issue":"7","key":"816_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41576-023-00574-0","volume":"24","author":"J Zschocke","year":"2023","unstructured":"Zschocke J, Byers PH, Wilkie AOM. Mendelian inheritance revisited: dominance and recessiveness in medical genetics. Nat Rev Genet. 2023;24(7):442\u201363.","journal-title":"Nat Rev Genet"},{"key":"816_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2021.11.021","volume":"524","author":"D He","year":"2022","unstructured":"He D, Li Y, Yang W, Chen S, Sun H, Li P, et al. Molecular diagnosis for growth hormone deficiency in Chinese children and adolescents and evaluation of impact of rare genetic variants on treatment efficacy of growth hormone. Clin Chim Acta. 2022;524:1\u201310.","journal-title":"Clin Chim Acta"},{"issue":"7","key":"816_CR19","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ajhg.2023.06.002","volume":"110","author":"LC Walker","year":"2023","unstructured":"Walker LC, Hoya M, Wiggins GAR, Lindy A, Vincent LM, Parsons MT, et al. Using the ACMG\/AMP framework to capture evidence related to predicted and observed impact on splicing: recommendations from the ClinGen SVI splicing subgroup. Am J Hum Genet. 2023;110(7):1046\u201367.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"816_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40246-017-0115-5","volume":"11","author":"L Zhytnik","year":"2017","unstructured":"Zhytnik L, Maasalu K, Reimann E, Prans E, Koks S, M\u00e4rtson A. Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients. Hum Genomics. 2017;11(1):19.","journal-title":"Hum Genomics"},{"issue":"1","key":"816_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/mgg3.331","volume":"6","author":"O Essawi","year":"2018","unstructured":"Essawi O, Symoens S, Fannana M, Darwish M, Farraj M, Willaert A, et al. Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families. Mol Genet Genom Med. 2018;6(1):15\u201326.","journal-title":"Mol Genet Genom Med"},{"key":"816_CR22","doi-asserted-by":"publisher","first-page":"116683","DOI":"10.1016\/j.bone.2023.116683","volume":"169","author":"AP Holtz","year":"2023","unstructured":"Holtz AP, Souza LT, Ribeiro EM, Acosta AX, Lago RMRS, Simoni G, et al. Genetic analysis of osteogenesis imperfecta in a large Brazilian cohort. Bone. 2023;169:116683.","journal-title":"Bone"},{"issue":"5","key":"816_CR23","first-page":"588","volume":"40","author":"LL Li","year":"2019","unstructured":"Li LL, Mao B, Li S, Xiao JF, Wang H, Zhang J, et al. Genotypic and phenotypic characterization of Chinese patients with osteogenesis imperfecta. Hum Mutat. 2019;40(5):588\u2013600.","journal-title":"Hum Mutat"},{"key":"816_CR24","doi-asserted-by":"publisher","first-page":"1149982","DOI":"10.3389\/fendo.2023.1149982","volume":"14","author":"K Salacinska","year":"2023","unstructured":"Salacinska K, Pinkier I, Rutkowska L, Chlebna-Sokol D, Jakubowska-Pietkiewicz E, Michalus I, et al. NGS analysis of collagen type I genes in Polish patients with osteogenesis imperfecta: a nationwide multicenter study. Front Endocrinol. 2023;14:1149982.","journal-title":"Front Endocrinol"},{"issue":"1","key":"816_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/genes13010124","volume":"13","author":"D Nadyrshina","year":"2022","unstructured":"Nadyrshina D, Zaripova A, Tyurin A, Minniakhmetov I, Zakharova E, Khusainova R. Osteogenesis imperfecta: search for mutations in patients from the Republic of Bashkortostan (Russia). Genes-Basel. 2022;13(1):124.","journal-title":"Genes-Basel"},{"issue":"6","key":"816_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/humu.9423","volume":"27","author":"KS Lee","year":"2006","unstructured":"Lee KS, Song HR, Cho TJ, Kim HJ, Lee TM, Jin HS, et al. Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta. Hum Mutat. 2006;27(6):599.","journal-title":"Hum Mutat"},{"issue":"2","key":"816_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/ocr.12218","volume":"21","author":"Z Jabbour","year":"2018","unstructured":"Jabbour Z, Al-Khateeb A, Eimar H, Retrouvey JM, Rizkallah J, Glorieux FH, et al. Genotype and malocclusion in patients with osteogenesis imperfecta. Orthod Craniofac Res. 2018;21(2):71\u20137.","journal-title":"Orthod Craniofac Res"},{"issue":"3","key":"816_CR28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.5507\/bp.2016.022","volume":"160","author":"L Hruskova","year":"2016","unstructured":"Hruskova L, Fijalkowski I, Van Hul W, Marik I, Mortier G, Martasek P, et al. Eight mutations including 5 novel ones in the COL1A1 gene in Czech patients with osteogenesis imperfecta. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016;160(3):442\u20137.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"816_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cca.2018.05.048","volume":"484","author":"NM Nawawi","year":"2018","unstructured":"Nawawi NM, Selveindran NM, Rasat R, Ping CY, Latiff ZA, Zakaria SZS, et al. Genotype-phenotype correlation among Malaysian patients with osteogenesis imperfecta. Clin Chim Acta. 2018;484:141\u20137.","journal-title":"Clin Chim Acta"},{"issue":"10","key":"816_CR30","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41431-023-01509-3","volume":"32","author":"KC Coetzer","year":"2024","unstructured":"Coetzer KC, Z\u00f6llner E, Moosa S. Genetic basis of osteogenesis imperfecta from a single tertiary centre in South Africa. Eur J Hum Genet. 2024;32(10):1285\u201390.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"816_CR31","doi-asserted-by":"publisher","first-page":"e1675","DOI":"10.1002\/mgg3.1675","volume":"9","author":"Y Higuchi","year":"2021","unstructured":"Higuchi Y, Hasegawa K, Futagawa N, Yamashita M, Tanaka H, Tsukahara H. Genetic analysis in Japanese patients with osteogenesis imperfecta: genotype and phenotype spectra in 96 probands. Mol Genet Genom Med. 2021;9(6):e1675.","journal-title":"Mol Genet Genom Med"},{"issue":"5","key":"816_CR32","doi-asserted-by":"publisher","first-page":"e0176466","DOI":"10.1371\/journal.pone.0176466","volume":"12","author":"K Andersson","year":"2017","unstructured":"Andersson K, Dahll\u00f6f G, Lindahl K, Kindmark A, Grigelioniene G, \u00c5str\u00f6m E, et al. Mutations in and and dental aberrations in children and adolescents with osteogenesis imperfecta-A retrospective cohort study. PLoS ONE. 2017;12(5):e0176466.","journal-title":"PLoS ONE"},{"key":"816_CR33","doi-asserted-by":"publisher","first-page":"935905","DOI":"10.3389\/fendo.2022.935905","volume":"13","author":"YZ Mei","year":"2022","unstructured":"Mei YZ, Zhang H, Zhang ZL. Comparing clinical and genetic characteristics of and inherited variants in a large Chinese cohort of osteogenesis imperfecta. Front Endocrinol. 2022;13:935905.","journal-title":"Front Endocrinol"},{"key":"816_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13023-015-0370-2","volume":"10","author":"HY Lin","year":"2015","unstructured":"Lin HY, Chuang CK, Su YN, Chen MR, Chiu HC, Niu DM, et al. Genotype and phenotype analysis of Taiwanese patients with osteogenesis imperfecta. Orphanet J Rare Dis. 2015;10:152.","journal-title":"Orphanet J Rare Dis"},{"key":"816_CR35","doi-asserted-by":"publisher","first-page":"116293","DOI":"10.1016\/j.bone.2021.116293","volume":"155","author":"B T\u00fcys\u00fcz","year":"2022","unstructured":"T\u00fcys\u00fcz B, Elkanova L, Alkaya DU, G\u00fcle\u00e7 C, Toksoy G, G\u00fcnes N, et al. Osteogenesis imperfecta in 140 Turkish families: molecular spectrum and, comparison of long-term clinical outcome of those with\/and biallelic variants. Bone. 2022;155:116293.","journal-title":"Bone"},{"key":"816_CR36","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3389\/fgene.2019.00722","volume":"10","author":"L Zhytnik","year":"2019","unstructured":"Zhytnik L, Maasalu K, Pashenkos A, Khmyzovs S, Reimann E, Prans E, et al. Pathogenic variants and phenotype characteristics in Ukrainian osteogenesis imperfecta patients. Front Genet. 2019;10:722.","journal-title":"Front Genet"},{"issue":"12","key":"816_CR37","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.medcli.2019.12.025","volume":"154","author":"PC Lafuente","year":"2020","unstructured":"Lafuente PC, Mu\u00f1oz AD, Alvarez SI, Lozano MF, San Ildefonso MM, Aizp\u00fan JIL. Osteogenesis imperfecta: review of 40 patients. Med Clin-Barcelona. 2020;154(12):512\u20138.","journal-title":"Med Clin-Barcelona"},{"issue":"4","key":"816_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/humu.9230","volume":"23","author":"L Ries-Levavi","year":"2004","unstructured":"Ries-Levavi L, Ish-Shalom T, Frydman M, Lev D, Cohen S, Barkai G, et al. Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients. Hum Mutat. 2004;23(4):399\u2013400.","journal-title":"Hum Mutat"},{"issue":"7","key":"816_CR39","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41431-019-0373-x","volume":"27","author":"M Maioli","year":"2019","unstructured":"Maioli M, Gnoli M, Boarini M, Tremosini M, Zambrano A, Pedrini E, et al. Genotype-phenotype correlation study in 364 osteogenesis imperfecta Italian patients. Eur J Hum Genet. 2019;27(7):1090\u2013100.","journal-title":"Eur J Hum Genet"},{"key":"816_CR40","first-page":"1","volume":"9999","author":"J Stephen","year":"2014","unstructured":"Stephen J, Shukla A, Dalal A, Girisha KM, Shah H, Gupta N, et al. Mutation spectrum of and genes in Indian patients with osteogenesis imperfecta. Am J Med Genet Part A. 2014;9999:1\u20138.","journal-title":"Am J Med Genet Part A"},{"issue":"1","key":"816_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40246-016-0083-1","volume":"10","author":"BH Duy","year":"2016","unstructured":"Duy BH, Zhytnik L, Maasalu K, K\u00e4ndla I, Prans E, Reimann E, et al. Mutation analysis of the and genes in Vietnamese patients with osteogenesis imperfecta. Hum Genomics. 2016;10(1):27.","journal-title":"Hum Genomics"},{"key":"816_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.metabol.2017.06.001","volume":"80","author":"S Tournis","year":"2018","unstructured":"Tournis S, Dede AD. Osteogenesis imperfecta-A clinical update. Metabolism. 2018;80:27\u201337.","journal-title":"Metabolism"},{"issue":"6","key":"816_CR43","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00223-024-01266-5","volume":"115","author":"M Jovanovic","year":"2024","unstructured":"Jovanovic M, Marini JC. Update on the genetics of osteogenesis imperfecta. Calcified Tissue Int. 2024;115(6):891\u2013914.","journal-title":"Calcified Tissue Int"},{"issue":"6","key":"816_CR44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/jmg.39.6.382","volume":"39","author":"A Marlowe","year":"2002","unstructured":"Marlowe A, Pepin MG, Byers PH. Testing for osteogenesis imperfecta in cases of suspected non-accidental injury. J Med Genet. 2002;39(6):382\u20136.","journal-title":"J Med Genet"},{"issue":"5","key":"816_CR45","doi-asserted-by":"publisher","first-page":"dmm049398","DOI":"10.1242\/dmm.049398","volume":"15","author":"N Garibaldi","year":"2022","unstructured":"Garibaldi N, Besio R, Dalgleish R, Villani S, Barnes AM, Marini JC, et al. Dissecting the phenotypic variability of osteogenesis imperfecta. Dis Model Mech. 2022;15(5):dmm049398.","journal-title":"Dis Model Mech"},{"issue":"4","key":"816_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ymeth.2005.07.015","volume":"37","author":"TA Cooper","year":"2005","unstructured":"Cooper TA. Use of minigene systems to dissect alternative splicing elements. Methods. 2005;37(4):331\u201340.","journal-title":"Methods"},{"issue":"1","key":"816_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/jbmr.2920","volume":"32","author":"L Folkestad","year":"2017","unstructured":"Folkestad L, Hald JD, Ersboll AK, Gram J, Hermann AP, Langdahl B, et al. Fracture rates and fracture sites in patients with osteogenesis imperfecta: A nationwide register-based cohort study. J Bone Min Res. 2017;32(1):125\u201334.","journal-title":"J Bone Min Res"},{"issue":"6","key":"816_CR48","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s10439-013-0793-7","volume":"41","author":"X Yao","year":"2013","unstructured":"Yao X, Carleton SM, Kettle AD, Melander J, Phillips CL, Wang Y. Gender-dependence of bone structure and properties in adult osteogenesis imperfecta murine model. Ann Biomed Eng. 2013;41(6):1139\u201349.","journal-title":"Ann Biomed Eng"},{"issue":"2","key":"816_CR49","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00223-022-00964-2","volume":"112","author":"A Ladang","year":"2023","unstructured":"Ladang A, Rauch F, Delvin E, Cavalier E. Bone turnover markers in children: from laboratory challenges to clinical interpretation. Calcif Tissue Int. 2023;112(2):218\u201332.","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"816_CR50","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1177\/10815589241254047","volume":"72","author":"J Jin","year":"2024","unstructured":"Jin J, Yue L, Lu Y, Zhen Z, Wu H, Shan X. Changes in serum bone turnover markers and bone mineral density Z-score in children with osteogenesis imperfecta after Zoledronic acid treatment. J Investig Med. 2024;72(7):715\u201322.","journal-title":"J Investig Med"},{"key":"816_CR51","doi-asserted-by":"crossref","unstructured":"Jiang YY, Mei YZ, Tian Y, Shen L, Xu SQ, Zhang H et al. The vitamin D status in a Chinese osteogenesis imperfecta population and its correlation with bone metabolic markers and bone density. Front Nutr. 2024;11:1390668.","DOI":"10.3389\/fnut.2024.1390668"},{"key":"816_CR52","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3389\/fgene.2019.00979","volume":"10","author":"LL Li","year":"2019","unstructured":"Li LL, Cao YX, Zhao FY, Mao B, Ren XZ, Wang YZ, et al. Validation and classification of atypical splicing variants associated with osteogenesis imperfecta. Front Genet. 2019;10:979.","journal-title":"Front Genet"},{"issue":"5","key":"816_CR53","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/cts.12783","volume":"13","author":"L Zhytnik","year":"2020","unstructured":"Zhytnik L, Maasalu K, Reimand T, Duy BH, Koks S, M\u00e4rtson A. Inter- and intrafamilial phenotypic variability in individuals with collagen-related osteogenesis imperfecta. Cts-Clin Transl Sci. 2020;13(5):960\u201371.","journal-title":"Cts-Clin Transl Sci"},{"issue":"7","key":"816_CR54","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.tig.2020.11.002","volume":"37","author":"F Supek","year":"2021","unstructured":"Supek F, Lehner B, Lindeboom RGH. To NMD or not to NMD: Nonsense-mediated mRNA decay in cancer and other genetic diseases. Trends Genet. 2021;37(7):657\u201368.","journal-title":"Trends Genet"},{"issue":"4","key":"816_CR55","first-page":"201","volume":"4","author":"AJ Payne","year":"2013","unstructured":"Payne AJ, Gerdes BC, Kaja S, Koulen P. Insert sequence length determines transfection efficiency and gene expression levels in bicistronic mammalian expression vectors. Int J Biochem Mol Biol. 2013;4(4):201\u20138.","journal-title":"Int J Biochem Mol Biol"},{"issue":"1","key":"816_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0945-053X(99)00056-6","volume":"19","author":"RL Slayton","year":"2000","unstructured":"Slayton RL, Deschenes SP, Willing MC. Nonsense mutations in the COL1A1 gene preferentially reduce nuclear levels of mRNA but not HnRNA in osteogenesis imperfecta type I cell strains. Matrix Biol. 2000;19(1):1\u20139.","journal-title":"Matrix Biol"},{"issue":"11","key":"816_CR57","doi-asserted-by":"publisher","first-page":"ziae125","DOI":"10.1093\/jbmrpl\/ziae125","volume":"8","author":"JJ Byrd","year":"2024","unstructured":"Byrd JJ, White AC, Nissen CG, Schissel M, Van Ormer M, Velasco D, et al. Genotype-phenotype correlations in 294 pediatric patients with osteogenesis imperfecta. JBMR Plus. 2024;8(11):ziae125.","journal-title":"JBMR Plus"},{"issue":"1","key":"816_CR58","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s40618-023-02123-2","volume":"47","author":"X Lin","year":"2024","unstructured":"Lin X, Hu J, Zhou B, Zhang Q, Jiang Y, Wang O, et al. Genotype-phenotype relationship and comparison between Eastern and Western patients with osteogenesis imperfecta. J Endocrinol Invest. 2024;47(1):67\u201377.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"816_CR59","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1086\/302512","volume":"65","author":"U Schwarze","year":"1999","unstructured":"Schwarze U, Starman BJ, Byers PH. Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: influence of intron splice order on outcome of splice-site mutation. Am J Hum Genet. 1999;65(2):336\u201344.","journal-title":"Am J Hum Genet"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00816-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-025-00816-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00816-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:22:52Z","timestamp":1756898572000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-025-00816-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["816"],"URL":"https:\/\/doi.org\/10.1186\/s40246-025-00816-8","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,31]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol was reviewed and ethically approved by the Institutional Review Board of the Affiliated Hospital of Jining Medical University (Approval No. 2019C003), in full compliance with the ethical principles established in the Declaration of Helsinki. Written informed consent was obtained from all participants prior to the collection of clinical data and publication of research findings.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent, including the permission to publish facial photos, has been obtained from the individual persons or their legal guardian.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}